Skip to main content

Research Repository

See what's under the surface

Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer

Rudraraju, Bharath; Droog, Marjolein; Abdel-Fatah, Tarek M.A.; Zwart, Wilbert; Giannoudis, Athina; Malki, Mohammed I.; Moore, David; Patel, Hetal; Shaw, Jacqui; Ellis, Ian O.; Chan, Steve; Brooke, Greg N.; Nevedomskaya, Ekaterina; Nigro, Christiana Lo; Carroll, Jason; Coombes, R. Charles; Bevan, Charlotte; Ali, Simak; Palmieri, Carlo

Authors

Bharath Rudraraju

Marjolein Droog

Tarek M.A. Abdel-Fatah

Wilbert Zwart

Athina Giannoudis

Mohammed I. Malki

David Moore

Hetal Patel

Jacqui Shaw

Steve Chan

Greg N. Brooke

Ekaterina Nevedomskaya

Christiana Lo Nigro

Jason Carroll

R. Charles Coombes

Charlotte Bevan

Simak Ali

Carlo Palmieri



Journal Article Type Article
Publication Date 2014-09
Journal Breast Cancer Research and Treatment
Print ISSN 0167-6806
Electronic ISSN 1573-7217
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
Volume 147
Issue 2
Pages 295-309
APA6 Citation Rudraraju, B., Droog, M., Abdel-Fatah, T. M., Zwart, W., Giannoudis, A., Malki, M. I., …Palmieri, C. (2014). Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer. Breast Cancer Research and Treatment, 147(2), 295-309. doi:10.1007/s10549-014-3098-0
DOI https://doi.org/10.1007/s10549-014-3098-0
Keywords Cancer Research; Oncology
Publisher URL https://link.springer.com/article/10.1007%2Fs10549-014-3098-0